Quantitative estimation of PCNA, c-myc, EGFR and TGF-α in oral submucous fibrosis - An immunohistochemical study

Oral Oncology

Volumn 37, Issue 5, 2001, Pages 461-467

  Srinivasan, M ^a   Jewell, S D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

c myc; EGFR; Oral submucous fibrosis; PCNA; Quantitative image analysis; TGF

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; ONCOPROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MARKER GENE; MOUTH DISEASE; MOUTH MUCOSA; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY;

ADULT; ANALYSIS OF VARIANCE; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL DIVISION; EPITHELIAL CELLS; FEMALE; GENES, MYC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MOUTH NEOPLASMS; ORAL SUBMUCOUS FIBROSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0034999827     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(00)00115-9     Document Type: Article

References (30)

1. Pindborg J.J. Oral submucous fibrosis. Oral Surg Med Oral Patho Oral Radiol Endod. 22:1966;764-769.
2. Wahi P.N., Kapur V.L., Luthra V.K., Srivatsava M.C. Submucous fibrosis of the oral cavity. 1. Clinical studies and 2. Studies on epidemiology. Bull Wld Hlth Org. 35:1966;789-799.
3. Haider S.M., Merchant A.T., Fikree F.F., Rahbar M.H. Clinical and functional staging of oral submucous fibrosis. Br J Oral Maxillofac Surg. 38:2000;12-15.
4. Pillai R., Balaram P., Sankara Reddiar K. Pathogenesis of oral submucous fibrosis. relationship to risk factors associated with oral cancer Cancer. 69:1992;1010-2011.
5. Kramer I.R.H. Basic histopathological features of oral premalignant lesions. Mackenzie I.C., Dabelstein E., Squier C.A. Oral Premalignancy. 1980;15-34 University of Iowa Press, Iowa City.
6. Pindborg J.J. Oral cancer & precancer: malignant potentials of oral precancerous lesions. 1980;John Wright, Bristol.
7. Paymaster J.C. Cancer of the buccal mucosa. a clinical study of 650 cases in Indian patients Cancer. 9:1956;431-435.
8. Pindborg J.J. Is submucous fibrosis a precancerous condition of the oral cavity? Int Dent J. 22:1972;474-480.
9. Pindborg J.J., Mehta F.S., Daftary D.K. Occurrence of epithelial atypia in 51 Indian villagers with oral submucous fibrosis. Cancer. 24:1970;253-257.
10. Murti P.R., Bhonsle R.B., Pindborg J.J., Daftary D.K., Gupta P.C., Mehta F.S. Malignant transformation rate in oral submucous fibrosis over a 17 year period. Comm Dent Oral Epidemiol. 13:1985;340-347.
11. Saranath D., Bhoite C.T., Deo M.G. Molecular lesions in human oral cancer: the Indian Scene. Oral Oncol Eur J Cancer. 29B(2):1993;107-112.
12. Field J.K. Oncogenes and tumor suppressor genes in squamous cell carcinoma of head and neck. Oral Oncol Eur. J Cancer. 28:1992;67-76.
13. Liu S.C., Klein-Szantom A.J.P. Markers of proliferation in normal and leukoplakic oral epithelia. Oral Oncol. 36:2000;145-151.
14. Cox S.C., Walker D.M. Epithelial growth fraction and expression of p53 tumor suppressor gene in oral submucous fibrosis. Aust Dent J. 41:1996;91-96.
15. Trivedi C., Warnakulasuriya K.A.S.S., Tavassoli M.et al. p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SCCP. J Oral Pathol Med. 27:1998;72-77.
16. Eversole L.R., Snapp J.P. C-myc oncoprotein expression in oral precancerous and early cancerous lesions. Oral Oncol. Eur J Cancer. 29B:1993;131-135.
17. Slim D.M., Varavud N., Ro J.Y., Lee J.S., Hong W.K., Hittelman W.N. Sequential increase in PCNA expression in head and neck tumorigenesis. a potential biomarker J Natl Cancer Ins. 85:1993;971-978.
18. Huang W.Y.F., Coltrera M., Schubert M., Morton T., Truelove E., Wash S. Histopathologic evaluation of proliferating cell nuclear antigen (PC 10) in oral epithelial hyperplasia and premalignant lesions. Oral Surg Med Oral Pathol Oral Radiol Endod. 78:1994;748-754.
19. Grandis J.R., Melhen M.F., Barnes E.L., Tweardy D.J. Quantitative immunohistochemical analysis of TGF-α and EGFR in patients with squamous cell carcinoma of head and neck. Cancer. 78:1996;1284-1292.
20. Grandis J.R., Tweardy D.J. Elevated levels of TGF-α and EGFR mRNA are early markers of carcinogenesis in head and neck cancer. Cancer Res. 53:1993;3579-3584.
21. Gapany M., Pavelic Z.P., Kelley D.J.et al. Immunohistochemical detection of c-myc protein in head and neck tumors. Arch Otolaryngol Head Neck Surg. 120:1994;255-259.
22. Pollack J.M., van Noordan S. An introduction to immunohistochemistry: current techniques and problems. 1988;Oxford University press, New York.
23. Gupta P.C., Sinor P.N., Bhonsle R.B., Pawar V.S., Mehta H.C. Oral submucous fibrosis in India. a new epidemic? Natl Med J India. 11(3):1998;113-116.
24. Shahn X., Sharma P.P. Role of chewing and smoking habits in the etiology of oral submucous fibrosis (OSF). a case-control study J Oral Pathol Med. 27:1998;475-479.
25. Rajendran R. Oral submucous fibrosis. etiology, pathogenesis, and future research Bull WHO. 72(6):1994;985-996.
26. Damlov I., Mildane B., Knowles B.B. Immunohistochemical localization of EGFR in normal human tissues. Lab Invest. 55:1986;588-592.
27. Todd R., Chou M.Y., Matossion K., Gallagher G.T., Donoff R.B., Wong D.J.W. Cellular sources of TGF-α in human oral cancer. J Dent Res. 70:1991;917-923.
28. Ghiabi M., Gallagher G.T., Wong D.T. Eosinophils, tissue eosinophilia, and eosinophil-derived transforming growth factor alpha in hamster oral carcinogenesis. Cancer Res Jan 15. 52(2):1992;389-393.
29. Haque M.F., Harris M., Meghji S., Speight P.M. An immunohistochemical study of oral submucous fibrosis. J Oral Pathol Med. 26:1997;75-82.
30. Haque M.F., Harris M., Meghji S., Barrett A.W. Immunolocalization of cytokines and growth factors in oral submucous fibrosis. Cytokine. 10(9):1998;713-719.